Psychomodulatory and anxiolytic effects of ACTH(4-7)-Pro-Gly-Pro and ACTH(6-9)-Pro-Gly-Pro against the background of experimental model of thyroid hyperfunction

The experimental study is devoted to the identification of possible psychomodulatory and anxiolytic effects of ACTH(4- 7)-Pro-Gly-Pro and ACTH(6-9)-Pro-Gly-Pro under conditions of thyroid hyperfunction. Material and methods. The experiment was performed on white male rats, which were divided into groups: I – control; II – rats with hyperthyroidism model, III and IV – animals receiving ACTH(4-7)-Pro-Gly-Pro (Semax) and ACTH(6-9)-Pro-Gly-Pro at doses of 174 and 178 μg/kg/day, respectively, for 21 days against the background of hyperthyroidism. The development of experimental hyperthyroidism in animals was induced by administration of an aqueous solution of potassium iodide at a dose of 75 µg/kg by intragastric gavage, daily for 3 weeks. Behavioural activity was assessed using psychopharmacological tests “Lattice” and “Light-Dark box” in standard modification. Results and discussion. Under conditions of experimental hyperthyroidism in the “Lattice” test, changes in psychomotor behaviour of animals were observed in the form of suppression of orienteering and exploratory activity, namely, a decrease in the number of stands and exploratory “peeks” downwards. In the test “Light-Dark box” against the background of thyroid hyperfunction, an increase in the level of anxiety was observed, manifested in a decrease in the time spent in the light compartment, the number of transitions between compartments and racks, as well as an increase in the number of assessments of “risk” – “looking out” of the compartment. The studied substances ACTH(4-7)-Pro-Gly-Pro and ACTH(6-9)-Pro-Gly-Pro in conditions of experimental hyperthyroidism promoted the correction of the above-mentioned behavioural disorders, eliminating the anxiety-depressive state of laboratory animals. Conclusions. When studying the effect of ACTH(4-7)-Pro-Gly-Pro and ACTH(6-9)-Pro-Gly-Pro substances under conditions of experimental hyperthyroidism on behavioural activity of white rats in the tests “Lattice” and “Light-Dark box” it was revealed that the studied peptide compounds exhibit psychomodulatory and anxiolytic effects, correcting behavioural reactions.

1. Niedowicz D.M., Wang W.X., Price D.A., Nelson P.T. Modulating thyroid hormone levels in adult mice: impact on behavior and compensatory brain changes. J. Thyroid Res. 2021;2021:13. doi: 10.1155/2021/9960188

2. Cole L.J., Farrell M.J., Gibson S.J., Egan G.F. Age-related differences in pain sensitivity and regional brain activity evoked by noxious pressure. Neurobiol. Aging. 2010;31(3):494–503. doi: 10.1016/j.neurobiolaging.2008.04.012

3. Dratman M.B., Martin J.V. The many faces of thyroxine. AIMS Neurosci. 2020;7(1):17–29. doi: 10.3934/Neuroscience.2020002

4. Stepien B.K., Huttner W.B. Transport, metabolism, and function of thyroid hormones in the developing mammalian brain. Front. Endocrinol. (Lausanne). 2019;10:209. doi: 10.3389/fendo.2019.00209

5. Menezes E.C., Santos P.R., Goes T.C., Carvalho V.C., Teixeira-Silva F., Stevens H.E., Badauê-Passos D.J. Jr. Effects of a rat model of gestational hypothyroidism on forebrain dopaminergic, GABAergic, and serotonergic systems and related behaviors. Behav. Brain Res. 2019;366:77–87. doi: 10.1016/j.bbr.2019.03.027

6. Becker R.A., Bykov Y.V. On the role of neuroendocrine abnormalities in the pathogenesis of cognitive dysfunction in major depressive disorder (a literature review with authors’ comments). Consilium Medicum. 2016;18(4):57–61. [In Russian].

7. Yasenyavskaya A.L., Samotrueva M.A., Tsibizova A.A., Bashkina O.A., Myasoedov N.F., Andreeva L.A. Effects of neuropeptides on behavior of rats in open field test and experimentally induced social stress. Archiv EuroMedica. 2020;10(3):25–28. doi: 10.35630/2199-885X/2020/10/3.5/

8. Yasenyavskaya A.L., Tsibizova A.A., Andreeva L.A., Myasoedov N.F., Bashkina O.A., Samotrueva M.A. Effect of glyprolines on the level of nerve growth factor in rats under conditions of «Social» stress. Vestnik Volgogradskogo gosudarstvennogo meditsinskogo universiteta = Journal of the Volgograd State Medical University. 2021;(4):55–59. [In Russian]. doi: 10.19163/1994-9480-2021-4(80)-55-59

9. Robinson M.V., Obut T.A., Melnikova E.V., Trufakin V.A. Indicators of cellular and humoral immunity in experimental hyperthyroidism and its correction. Byulleten’ eksperimental’noy biologii i meditsiny = Bulletin of Experimental Biology and Medicine. 2013;156(10):460–462. [In Russian].

10. Zhang L., Schallert T., Zhang Z.G., Jiang Q., Arniego P., Li Q., Lu M., Chopp M. A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J. Neurosci. Methods. 2002;117(2):207–214. doi: 10.1016/s0165-0270(02)00114-0

11. Kade A.Kh., Kravchenko S.V., Trofimenko A.I., Polyakov P.P., Lipatova A.S., Ananyeva E.I., Chaplygina K.Yu., Uvarova E.A., Tereschenko O.A. Modern methods of anxiety assessment of rodents by tests based on unconditional behavior models. Kubanskiy nauchnyy meditsinskiy vestnik = Kuban Scientific Medical Bulletin. 2018;25(6):171–176. [In Russian]. doi: 10.25207/1608-6228-2018-25-6-171-176

12. Liu Y.Y., Brent G.A. Thyroid hormone and the brain: Mechanisms of action in development and role in protection and promotion of recovery after brain injury. Pharmacol. Ther. 2018;186:176–185. doi: 10.1016/j.pharmthera.2018.01.007

13. Vorvul A.O., Bobyntsev I.I., Svishcheva M.V., Medvedeva O.A., Mukhina A.Yu., Andreeva L.A. Peptide ACTH4–7-PGP ameliorates behaviour and stabilize corticosterone level in rats affected with chronic stress. Rossiyskiy fiziologicheskiy zhurnal imeni Ivana Mikhaylovicha Sechenova = Russian Journal of Physiology. 2021;107(11):1359–1371. [In Russian]. doi: 10.31857/S0869813921110108

14. Molnár I. Interactions among thyroid hormone (FT4), chemokine (MCP-1) and neurotrophin (NGF-β) levels studied in Hungarian postmenopausal and obese women. Cytokine. 2020;127:154948. doi: 10.1016/j.cyto.2019.154948

15. Khaleghzadeh-Ahangar H., Talebi A., Mohseni-Moghaddam P. Thyroid disorders and development of cognitive impairment: a review study. Neuroendocrinology. 2022;112(9):835–844. doi: 10.1159/000521650

16. Hernandez A. Cognitive function in hypothyroidism: what is that deiodinase again? J. Clin. Invest. 2019;129(1):55–57. doi: 10.1172/JCI125203

17. Tamijani S.M., Karimi B., Amini E., Golpich M., Dargahi L., Ali R.A., Ibrahim N.M., Mohamed Z., Ghasemi R., Ahmadiani A. Thyroid hormones: Possible roles in epilepsy pathology. Seizure. 2015;31:155–164. doi: 10.1016/j.seizure.2015.07.021

18. Jurado-Flores M., Warda F., Mooradian A. Pathophysiology and clinical features of neuropsychiatric manifestations of thyroid disease. J. Endocr. Soc. 2022;6(2):bvab194. doi: 10.1210/jendso/bvab194